TY - JOUR
T1 - Rationale, implementation considerations, delineation and planning target objective recommendations for volumetric modulated arc therapy and helical tomotherapy total body irradiation, total marrow irradiation, total marrow and lymphoid irradiation and total lymphoid irradiation
AU - Hoeben, Bianca A.W.
AU - Saldi, Simonetta
AU - Aristei, Cynthia
AU - Engellau, Jacob
AU - Ocanto, Abrahams
AU - Hiniker, Susan M.
AU - Misson-Yates, Sarah
AU - Kobyzeva, Daria A.
AU - Pazos, Montserrat
AU - George Mikhaeel, N.
AU - Rodriguez-Roldan, Marta
AU - Seravalli, Enrica
AU - Bosman, Mirjam E.
AU - Han, Chunhui
AU - Losert, Christoph
AU - Engström, Per E.
AU - Fulcheri, Christian P.L.
AU - Zucchetti, Claudio
AU - Ferrer, Carlos
AU - Hussein, Mohammad
AU - Loginova, Anna A.
AU - Clark, Catharine H.
AU - Wong, Jeffrey Y.C.
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/5
Y1 - 2025/5
N2 - As a component of myeloablative conditioning before allogeneic hematopoietic stem cell transplantation (HSCT), Total Body Irradiation (TBI) is employed in radiotherapy centers all over the world. In recent and coming years, many centers are changing their TBI setup to a conformal isocentric technique, providing superior homogeneity and control of the target prescription dose, and more freedom for individualized organ-at-risk sparing or dose-escalation. Also, more specifically bone-marrow- and/or lymphatics-targeted therapies such as Total Marrow (+ Lymphoid) Irradiation (TMI / TMLI), and Total Lymphoid Irradiation (TLI) are established and prospectively evaluated in several centers. With each center developing their own methods, a new practice heterogeneity is arising, as was the case for decades with conventional TBI. To provide a ground base – and therefore more options for more homogeneous and comparable practice − for centers who are implementing conformal isocentric techniques, a group of early adopters of isocentric conformal TBI and TM(L)I came together to convey issues they encountered during clinical implementation, and form consensus recommendations for delineation and planning targets, based on available literature evaluation and shared experience. These recommendations follow previously published recommendations regarding technical setup of conformal isocentric TBI / TM(L)I techniques.
AB - As a component of myeloablative conditioning before allogeneic hematopoietic stem cell transplantation (HSCT), Total Body Irradiation (TBI) is employed in radiotherapy centers all over the world. In recent and coming years, many centers are changing their TBI setup to a conformal isocentric technique, providing superior homogeneity and control of the target prescription dose, and more freedom for individualized organ-at-risk sparing or dose-escalation. Also, more specifically bone-marrow- and/or lymphatics-targeted therapies such as Total Marrow (+ Lymphoid) Irradiation (TMI / TMLI), and Total Lymphoid Irradiation (TLI) are established and prospectively evaluated in several centers. With each center developing their own methods, a new practice heterogeneity is arising, as was the case for decades with conventional TBI. To provide a ground base – and therefore more options for more homogeneous and comparable practice − for centers who are implementing conformal isocentric techniques, a group of early adopters of isocentric conformal TBI and TM(L)I came together to convey issues they encountered during clinical implementation, and form consensus recommendations for delineation and planning targets, based on available literature evaluation and shared experience. These recommendations follow previously published recommendations regarding technical setup of conformal isocentric TBI / TM(L)I techniques.
KW - Consensus recommendations
KW - Hematopoietic stem cell transplantation
KW - Total Body Irradiation
KW - Total Lymphoid Irradiation
KW - Total Marrow and Lymphoid Irradiation
KW - Total Marrow Irradiation
UR - http://www.scopus.com/inward/record.url?scp=85218441968&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2025.110822
DO - 10.1016/j.radonc.2025.110822
M3 - Review article
AN - SCOPUS:85218441968
SN - 0167-8140
VL - 206
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
M1 - 110822
ER -